glp-1 images One in 10 people may have resistance to diabetes drugs What are GLP-1 Medications? 9

Ongoing Communication: Maintain open and honest communication with your healthcare providers throughout your treatment journey

Ultsch et al., 2016

During the following 26 weeks of treatment (extension phase), discontinuations as a result of adverse events occurred in 2.4% of patients in the T-T group (patients treated with tesamorelin for Week 0-26 and with tesamorelin for Week 26-52) and 5.2% of patients in the T-P group (patients treated with tesamorelin for Week 0-26 and with placebo for Week 26-52)

Symptoms may include right upper abdominal pain, fever, nausea, vomiting, or jaundice, and require prompt medical assessment

5) OConnor JE et al

Allmax Liquid L-Carnitine vs